CF PharmTech picks up $90 mln Series E

CF PharmTech Inc, a provider of respiratory drug products, has raised $90 million in Series E funding.

CF PharmTech Inc, a provider of respiratory drug products, has raised $90 million in Series E funding. New Alliance Capital led the round.

Source: Press Release